Source link : https://www.newshealth.biz/health-news/camrelizumab-helpful-addition-to-breast-cancer-treatment/
TOPLINE: Adding camrelizumab to neoadjuvant chemotherapy increases pathological complete response rate to 56.8% vs 44.7% with placebo in early or locally advanced triple-negative breast cancer. The combination shows consistent benefits across patient subgroups with a manageable safety profile. METHODOLOGY: A randomized, double-blind, phase 3 trial enrolled 441 females (median age, 48 years) with early or […]
Author : News Health
Publish date : 2024-12-17 07:01:45
Copyright for syndicated content belongs to the linked Source.